BERT-based Transfer Learning in Sentence-level Anatomic Classification of Free-Text Radiology Reports.

Purpose: To assess whether transfer learning with a bidirectional encoder representations from transformers (BERT) model, pretrained on a clinical corpus, can perform sentence-level anatomic classification of free-text radiology reports, even for anatomic classes with few positive examples. Materials and Methods: This retrospective study included radiology reports of patients who underwent whole-body PET/CT imaging from December 2005 to December 2020. Each sentence in these reports (6272 sentences) was labeled by two annotators according to body part ("brain," "head & neck," "chest," "abdomen," "limbs," "spine," or "others"). The BERT-based transfer learning approach was compared with two baseline machine learning approaches: bidirectional long short-term memory (BiLSTM) and the count-based method. Area under the precision-recall curve (AUPRC) and area under the receiver operating characteristic curve (AUC) were computed for each approach, and AUCs were compared using the DeLong test. Results: The BERT-based approach achieved a macro-averaged AUPRC of 0.88 for classification, outperforming the baselines. AUC results for BERT were significantly higher than those of BiLSTM for all classes and those of the count-based method for the "brain," "chest," "abdomen," and "others" classes (P values < .025). AUPRC results for BERT were superior to those of baselines even for classes with few labeled training data (brain: BERT, 0.95, BiLSTM, 0.11, count based, 0.41; limbs: BERT, 0.74, BiLSTM, 0.28, count based, 0.46; spine: BERT, 0.82, BiLSTM, 0.53, count based, 0.69). Conclusion: The BERT-based transfer learning approach outperformed the BiLSTM and count-based approaches in sentence-level anatomic classification of free-text radiology reports, even for anatomic classes with few labeled training data.Keywords: Anatomy, Comparative Studies, Technology Assessment, Transfer Learning Supplemental material is available for this article. © RSNA, 2023.

Incidence and management of cystic duct perforation during endoscopic transpapillary gallbladder drainage for acute cholecystitis.

BACKGROUND AND AIM: Evidence regarding the incidence and clinical outcome of cystic duct perforation (CDP) during endoscopic transpapillary gallbladder drainage (ETGBD) is inadequate. The present study aimed to evaluate the incidence and management of CDP during ETGBD. METHODS: Between March 2011 and December 2019, 249 patients underwent initial ETGBD for acute cholecystitis. The incidence of CDP was retrospectively examined and the outcomes between the CDP and non-CDP groups were compared. RESULTS: CDP during ETGBD occurred in 23 (9.2%) of 249 patients (caused by guidewire in 15 and cannula in 8). ETGBD was successful in 10 patients following CDP. In 13 patients who failed ETGBD, 11 underwent bile duct drainage during the same session; nine patients underwent gallbladder decompression by other methods, such as percutaneous drainage. Clinical resolution for acute cholecystitis was achieved in 20 patients, and no bile peritonitis was noted. ETGBD technical success rates (45.3% vs. 91.2%, p < 0.001), ETGBD procedure times (66.5 vs. 54.8 min, p = 0.041), and hospitalization periods (24.5 vs. 18.7 days, p = 0.028) were significantly inferior in the CDP group (n = 23) compared with the non-CDP group (n = 216). There were no differences in clinical success and adverse events other than CDP between both groups. CONCLUSIONS: Cystic duct perforation reduced the ETGBD technical success rate. However, even in patients with cystic duct perforation, an improvement of acute cholecystitis was achieved by subsequent successful ETGBD or additional procedures, such as percutaneous drainage.

[Change in patient satisfaction in outpatient chemotherapy unit--comparison in 2005 and 2008].

We investigated the influences of the treatment environment, in terms of the increased number of treatments, introduction of regimen assessment and registration system, and the levels of specialization of the concerned medical professionals on patient satisfaction. We compared our results with those of a previous survey conducted in the outpatient chemotherapy unit of Hirosaki University Hospital. The patients were satisfied with respect to the privacy considerations and waiting time. However, a decrease in the patient instruction time led to slightly lower patient satisfaction. We concluded that it is useful to evaluate the quality of treatment in terms of patient satisfaction in a hospital.

[Effect of preliminary medication on oxaliplatin hypersensitivity].

Oxaliplatin therapy is a standard treatment for advanced colorectal cancer, and oxaliplatin hypersensitivity is one of its side effects that should be particularly considered. In the present study, we observed a decrease in the incidence of oxaliplatin hypersensitivity since the introduction of preliminary medication involving the administration of escalated doses of steroids and the use of antihistamine agents. From the medical economics perspective, although the costs of the preliminary medication were generated, those for the treatment of oxaliplatin hypersensitivity, which were higher than the total cost of the preliminary medication, needed to be generated for all patients. Introduction of preliminary medication decreased the overall cost, since the medication decreased the incidence of hypersensitivity. Therefore, preliminary medication was recognized to be effective from the perspective of medical economics. The preliminary medication we introduced contributed to a safe, cost-effective, and high-quality treatment for advanced colorectal cancer by preventing oxaliplatin hypersensitivity.

[Survey on antiemetic therapy in ambulatory cancer chemotherapy and medical economics for standardization].

A cancer chemotherapy unit was established to support therapy for outpatients with cancer in Hirosaki University Hospital. It is essential to standardize antiemetic therapy, since a wide variety of the therapy provided to the unit from the diagnosis and treatment departments were conventional and empirical. We surveyed the use conditions and compatibility of the therapy based on reliable guidelines, and then considered the medical economics for standardization. In moderate-grade emetogenic chemotherapy, 5-HT(3) receptor antagonists tended to be used frequently instead of the recommended steroids. From this survey, the standardization of the cost of 5-HT(3) receptor antagonists and the relatively inexpensive steroids used in cancer chemotherapy might reduce either the nausea or vomiting suffered by patients with cancer and their economic burden as well.